EPO Patents = 2

Forward Citations = 0

Loading Chart...

2 inventors (with patents filed for the assignee):

Reto Naef (6 out of 13 patents)

Hermann Tenor (6 out of 13 patents)

6 patents: Sort by Forward Citations

1. 12351585 - 2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof (2025-07-08),

2. 11905293 - Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof (2024-02-20),

3. 11897890 - 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof (2024-02-13),

4. 11242347 - 2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof (2022-02-08),

5. 11155558 - Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof (2021-10-26),

6. 10570137 - 2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof (2020-02-25),

Topadur Pharma Ag is a pharmaceutical company focused on developing innovative therapies for dermatological conditions. With a dedicated team of researchers and scientists, Topadur Pharma Ag is committed to improving the lives of patients with skin disorders through the development of cutting-edge treatments. The company's mission is to provide effective and safe solutions for various dermatological conditions, ultimately helping patients achieve healthier skin.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#14 in Schlieren

#1,443 in Switzerland

Schlieren, Switzerland

Topadur Pharma Ag

Forward Citations = 0

2 inventors:

Reto Naef (6 out of 13 patents)

Hermann Tenor (6 out of 13 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com